These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 7887015)

  • 1. Comparative efficacy of biodegradable liposomes and microspheres as carriers for delivery of Vibrio cholerae antigens in the intestine.
    Chandrasekhar U; Sinha S; Bhagat HR; Sinha VB; Srivastava BS
    Vaccine; 1994 Nov; 12(15):1384-8. PubMed ID: 7887015
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of the flagellar antigens of Vibrio cholerae El Tor and their role in protection.
    Sinha VB; Jacob A; Srivastava R; Kaper JB; Srivastava BS
    Vaccine; 1993; 11(3):372-5. PubMed ID: 8447164
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of a 33 kDa antigen associated with an adhesive and colonizing strain of Vibrio cholerae El Tor and its role in protection.
    Jacob A; Sinha VB; Sahib MK; Srivastava R; Kaper JB; Srivastava BS
    Vaccine; 1993; 11(3):376-82. PubMed ID: 8447165
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CpG DNA, liposome and refined antigen oral cholera vaccine.
    Leelawongtawon R; Somroop S; Chaisri U; Tongtawe P; Chongsa-nguan M; Kalambaheti T; Tapchaisri P; Pichyangkul S; Sakolvaree Y; Kurazono H; Hayashi H; Chaicumpa W
    Asian Pac J Allergy Immunol; 2003 Dec; 21(4):231-9. PubMed ID: 15198341
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunological responses of rabbits to various somatic and secreted antigens of Vibrio cholerae after intra-duodenal inoculation.
    Kabir S
    J Med Microbiol; 1987 Aug; 24(1):29-40. PubMed ID: 3612742
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunogenicity of liposome-associated oral cholera vaccine prepared from combined Vibrio cholerae antigens.
    Chaicumpa W; Parairo JR; New RC; Pongponratn E; Ruangkunaporn Y; Tapchaisri P; Chongsa-nguan M
    Asian Pac J Allergy Immunol; 1990 Dec; 8(2):87-94. PubMed ID: 2091663
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stimulation of mucosal immune response following oral administration of enterotoxigenic Escherichia coli fimbriae (CFA/I) entrapped in liposomes in conjunction with inactivated whole-cell Vibrio cholerae vaccine.
    Dima VF; Ionescu MD; Palade R; Balotescu C; Becheanu G; Dima SV
    Roum Arch Microbiol Immunol; 2001; 60(1):27-54. PubMed ID: 11850896
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunogenicity and protective role of three formulations of oral cholera vaccine.
    Kalambaheti T; Chaisri U; Srimanote P; Pongponratn E; Chaicumpa W
    Vaccine; 1998; 16(2-3):201-7. PubMed ID: 9607031
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Study of intestinal immunity against V. cholerae: role of antibody to V. cholerae haemagglutinin in intestinal immunity.
    Chaicumpa W; Atthasisiha N
    Southeast Asian J Trop Med Public Health; 1977 Mar; 8(1):13-8. PubMed ID: 887992
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanisms of disease and immunity in cholera: a review.
    Holmgren J; Svennerholm AM
    J Infect Dis; 1977 Aug; 136 Suppl():S105-12. PubMed ID: 197173
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The study of intestinal immunity against V. cholerae: purification of V. cholerae El Tor haemagglutinin and the protective role of its antibody in experimental cholera.
    Chaicumpa W; Atthasishtha N
    Southeast Asian J Trop Med Public Health; 1979 Mar; 10(1):73-80. PubMed ID: 483020
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sublingual Adjuvant Delivery by a Live Attenuated Vibrio cholerae-Based Antigen Presentation Platform.
    Liao J; Gibson JA; Pickering BS; Watnick PI
    mSphere; 2018 Jun; 3(3):. PubMed ID: 29875145
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Experimental studies on cholera immunization. 4. The antibody response to formalinized Vibrio cholerae and purified endotoxin with special reference to protective capacity.
    Svennerholm AM
    Int Arch Allergy Appl Immunol; 1975; 49(4):434-52. PubMed ID: 808500
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Intestinal antibodies against lipopolysaccharide antigens of NAG vibrio in rabbits immunized by the oral route (author's transl)].
    Ciznár I; Bartková G; Hostacká A; Karolcek J
    Cesk Epidemiol Mikrobiol Imunol; 1979 Jul; 28(4):193-200. PubMed ID: 159131
    [No Abstract]   [Full Text] [Related]  

  • 15. Antigenic analysis of Vibrio cholerate O1 by crossed immunoelectrophoresis.
    Kabir S
    Zentralbl Bakteriol Mikrobiol Hyg A; 1989 Jan; 270(3):361-72. PubMed ID: 2929189
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Preparation of oral microspheres carrying V. cholera vaccine and its target's distribution].
    Zhang W; Jia W; Liu C
    Hua Xi Yi Ke Da Xue Xue Bao; 1999 Mar; 30(1):31-3. PubMed ID: 12205916
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preparation and immunogenicity of a bivalent cell-surface protein-polysaccharide conjugate of Vibrio cholerae.
    Kabir S
    J Med Microbiol; 1987 Feb; 23(1):9-18. PubMed ID: 3820275
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of the protective efficacy of Vibrio cholerae ghost (VCG) candidate vaccines in rabbits.
    Eko FO; Schukovskaya T; Lotzmanova EY; Firstova VV; Emalyanova NV; Klueva SN; Kravtzov AL; Livanova LF; Kutyrev VV; Igietseme JU; Lubitz W
    Vaccine; 2003 Sep; 21(25-26):3663-74. PubMed ID: 12922096
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oral immunization in adult mice to live and heat-killed Vibrio cholerae.
    Fujisawa H; Tsuru S; Taniguchi M; Zinnaka Y
    Microbiol Immunol; 1987; 31(8):763-70. PubMed ID: 3683219
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intestinal antibodies in rats following exposure to live Vibrio cholerae.
    Cooper GN; McNab CE; Walker PG; Jackson GD
    Aust J Exp Biol Med Sci; 1984 Aug; 62 ( Pt 4)():465-77. PubMed ID: 6517765
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.